Peyto Reports First Quarter 2024 Results
GlobeNewswire
CALGARY, Alberta, May 14, 2024 (GLOBE NEWSWIRE) -- Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto" or the "Company") is..
Cascade Range
News and Video Search Results
News coverage
-
Global Green Cooling Technologies Market Trends, Opportunity & Forecast, 2019-2024 & 2029F
GlobeNewswire
-
Outdoor Products Market to Hit Sale Valuation of USD 129.10 Billion By 2032: Astute Analytica
GlobeNewswire
-
The Interlocking Of Strategic Paradigms – OpEd
Eurasia Review
-
GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
GlobeNewswire
0 shares
1 views
You might like
Cascade Range media coverage
Preliminary Results for the Year Ended 31 December 2023
GlobeNewswire
19 April 2024
*Biodexa Pharmaceuticals PLC*
(“Biodexa” or the “Company” or, together with its subsidiaries,..
-
Global Quantum Technology Industry Research 2024: Market will Reach $61.3 Billion by 2029 - Developments in the Areas of Hybrid Quantum Applications, Quantum Machine Learning, and Much More
GlobeNewswire
-
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
GlobeNewswire
-
Anycubic Unveils 2024 Strategy to Refine 3D Printing Experience
PR Newswire Asia
-
Highlights of the 2024 season at Canada’s Wonderland include new giant boomerang water slide and expanded event dates
GlobeNewswire
Advertisement
More coverage
Diagonal Therapeutics Launches with $128 Million in Financing to Pioneer a New Approach to Discovering and Developing Agonist Antibodies to Tackle the Underlying Causes of Severely Debilitating Diseases
GlobeNewswire
- DIAGONAL platform, combining proprietary computational and experimental techniques to identify rare agonist antibodies that..
-
Full Schedule Released for Hong Kong Web3 Festival 2024
PR Newswire Asia
-
Photoneo’s Fastest High-accuracy MotionCam-3D Camera Now Ready for Fizyr’s New Vision Packs
Pressat
-
Food Allergy Treatment Drug Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Vedanta Biosciences, Novartis, Alladapt Immunotherapeutics, Regeneron Pharmaceuticals, Genentech, Parexel
GlobeNewswire
-
IDS Brings its Industrial Cameras to Fizyr’s New Vision Packs
Pressat